- Digital therapeutics (DTx), which deliver evidence-based therapeutic interventions via software to prevent, manage, or treat medical conditions, are becoming an integral component of the healthcare landscape in the Asia-Pacific region due to their scalability, remote access capabilities, and ability to support chronic disease management and mental health care
- The growing demand for DTx in Asia-Pacific is primarily driven by the rising incidence of lifestyle-related chronic diseases, increasing focus on preventive healthcare, and heightened awareness of digital health solutions among both patients and healthcare providers
- Japan dominated the Asia-Pacific digital therapeutic (DTx) market with the largest revenue share of 37.3% in 2024, supported by its advanced healthcare infrastructure, aging population, and favorable regulatory pathways, with notable progress in the adoption of digital platforms for mental health and chronic disease management
- India is expected to be the fastest growing country in the Asia-Pacific digital therapeutic (DTx) market during the forecast period, owing to increasing smartphone penetration, improved internet connectivity, growing burden of chronic conditions, and rising focus on affordable digital healthcare solutions
- Group purchase organization segment dominated the Asia-Pacific digital therapeutic (DTx) market with a market share of 54.6% in 2024, driven by its ability to streamline procurement, reduce costs, and enable large-scale adoption through healthcare institutions and employer networks
